Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure

AH Wu, JK Ghali, GW Neuberg, CM O'Connor… - American heart …, 2010 - Elsevier
BACKGROUND: Previous studies have not extensively examined the association of
hyperuricemia and adverse outcomes in systolic heart failure (HF) in relation to xanthine …
被引用次数：96 相关文章

Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure

AH Wu, JK Ghali, GW Neuberg, CM O'Connor… - American Heart …, 2010 - infona.pl
Previous studies have not extensively examined the association of hyperuricemia and
adverse outcomes in systolic heart failure (HF) in relation to xanthine oxidase inhibitor …

Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure

AH Wu, JK Ghali, GW Neuberg, CM O'Connor… - 2010 - pubmed.ncbi.nlm.nih.gov
Background Previous studies have not extensively examined the association of
hyperuricemia and adverse outcomes in systolic heart failure (HF) in relation to xanthine …

[引用][C] Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure

WU AH - Am Heart J, 2010 - cir.nii.ac.jp
[PDF] academia.edu

[PDF][PDF] Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure

AH Wu, JK Ghali, GW Neuberg… - American Heart …, 2010 - academia.edu
Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart
failure Page 1 Uric acid level and allopurinol use as risk markers of mortality and morbidity in …

Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure.

AH Wu, JK Ghali, GW Neuberg, CM O'Connor… - American Heart …, 2010 - europepmc.org
Background Previous studies have not extensively examined the association of
hyperuricemia and adverse outcomes in systolic heart failure (HF) in relation to xanthine …

[引用][C] Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure

AH WU, JK GHALI, GW NEUBERG… - The American heart …, 2010 - pascal-francis.inist.fr
Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart
failure CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …

[引用][C] Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure

AH Wu, JK Ghali, GW Neuberg, CM O'Connor… - American Heart …, 2010 - cir.nii.ac.jp
Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart
failure | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データを …
[PDF] academia.edu

[PDF][PDF] Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure

AH Wu, JK Ghali, GW Neuberg… - American Heart …, 2010 - academia.edu
Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart
failure Page 1 Uric acid level and allopurinol use as risk markers of mortality and morbidity in …

[引用][C] Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure

AH WU, JK GHALI, GW NEUBERG… - The American heart …, 2010 - Mosby